NCT07321899ClinicalTrials.gov
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
En resumen
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
De intervención1186 participantes buscados20 centros1 país
Categorías
Registrado en 1 registro
- ClinicalTrials.govNCT07321899Abrir este registro en ClinicalTrials.govSincronizado la semana pasada
Un mismo estudio puede estar registrado en varios registros. Lo mostramos una sola vez y enlazamos con todos los registros que tenemos.
La información del ensayo se muestra tal como la publicó el registro, en su idioma original.
¿Le interesa este estudio?
Iniciar sesión o cree una cuenta para registrar su interés y seguir este estudio.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding7/20
Single-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 4 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,186 participants (target), run at 20 sites.
How this score is built
- Enrolment31/40
1,186 participants (target)
- Site count7/25
4 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 179 months
- Sponsor scale4/10
Medtronic Cardiovascular has led 19 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Resumen
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Afecciones
- Severe Tricuspid Regurgitation
Elegibilidad
| Sexo | Todos |
|---|---|
| Edades | 18 Years – Sin máximo |
| Voluntarios sanos | No |
Elegibilidad tal como figura en el registro
Elegibilidad en frases sencillas
Los criterios de este registro aún no se han desglosado en frases separadas. El texto del registro anterior está completo y es la versión autorizada.
Diseño del estudio
| Tipo de estudio | De intervención |
|---|---|
| Fase | No aplicable |
| Asignación | Aleatorizado |
| Modelo de intervención | PARALLEL |
| Propósito principal | TREATMENT |
| Enmascaramiento | SINGLE (1) |
| Inscripción | 1186 participantes buscados |
Patrocinador y colaboradores
- Medtronic Cardiovascular Patrocinador
Grupos e intervenciones
- Medtronic Intrepid™ TTVREXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
- Edwards EVOQUE TTVRACTIVE_COMPARATOR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
- Single Arm RegistryEXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
Intervenciones
- Dispositivo Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
- Dispositivo Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
Variables de resultado
Variable de resultado principal
Rate of Major Adverse Events (MAE)
Plazo 30-days post-procedure
Variable de resultado principal
Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention
Plazo 1-year post-procedure
Variable de resultado secundaria
Tricuspid regurgitation (TR) grade reduction
Total number of patients with at least one grade TR reduction
Plazo 6 months post-procedure
Variable de resultado secundaria
Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline
KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life
Plazo 6 months post-procedure
Variable de resultado secundaria
All-cause mortality
Plazo 12 months post-procedure
Variable de resultado secundaria
Heart failure hospitalization
Plazo 12 months post-procedure
Variable de resultado secundaria
New onset conduction disturbance (NOCD)
Plazo 30 days post-procedure
Variable de resultado secundaria
Total procedure time
Plazo Procedure
Variable de resultado secundaria
Right ventricle (RV) dysfunction
Plazo 12 months post-procedure
Fechas
| Fecha de inicio | 11 de septiembre de 2026 (real) |
|---|---|
| Finalización principal | 1 de septiembre de 2031 (estimada) |
| Finalización | 1 de abril de 2041 (estimada) |
| Primera publicación | 7 de enero de 2026 (real) |
| Última actualización | 12 de noviembre de 2026 |
| Resultados publicados | No indicado en el registro |
| Estado verificado por última vez | noviembre de 2026 |
Real significa que el evento ocurrió. Estimada significa que el patrocinador lo prevé. Ambas cosas significan algo distinto.
Ubicaciones
20 centros están en reclutamiento
United States
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | En reclutamiento |
| University of Alabama at Birmingham (UAB) Hospital | Birmingham | Alabama | En reclutamiento |
| Buffalo General Medical Center | Buffalo | New York | En reclutamiento |
| Northwestern Memorial Hospital | Chicago | Illinois | En reclutamiento |
| The Christ Hospital | Cincinnati | Ohio | En reclutamiento |
| Cleveland Clinic Foundation | Cleveland | Ohio | En reclutamiento |
| Hartford Hospital | Hartford | Connecticut | En reclutamiento |
| Cedars Sinai Medical Center | Los Angeles | California | En reclutamiento |
| Northwell Health North Shore University Hospital | Manhasset | New York | En reclutamiento |
| Abbott Northwestern Hospital | Minneapolis | Minnesota | En reclutamiento |
| Morristown Medical Center | Morristown | New Jersey | En reclutamiento |
| Yale New Haven Hospital | New Haven | Connecticut | En reclutamiento |
| Montefiore Medical Center | New York | New York | En reclutamiento |
| NYU Langone Medical Center | New York | New York | En reclutamiento |
| The Valley Hospital | Paramus | New Jersey | En reclutamiento |
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | En reclutamiento |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | En reclutamiento |
| Los Robles Hospital & Medical Center | Thousand Oaks | California | En reclutamiento |
| Ascension Via Christi Saint Francis | Wichita | Kansas | En reclutamiento |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | En reclutamiento |
Documentos del estudio
No hay documentos enlazados en este registro.
Cambios a lo largo del tiempo
- 12 de noviembre de 2026
Centro añadido
7 sites added (20 total)
1320
- 25 de septiembre de 2026
Centro añadido
9 sites added (13 total)
413
- 28 de julio de 2026
Estado modificado
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28 de julio de 2026
Reclutamiento abierto
Recruitment opened
NOT_YET_RECRUITINGRECRUITING
- 28 de julio de 2026
Centro añadido
4 sites added (4 total)
04